tradingkey.logo

Tempus AI Inc

TEM

56.590USD

-1.220-2.11%
Fechamento 07/31, 16:00ETCotações atrasadas em 15 min
9.79BValor de mercado
PerdaP/L TTM

Tempus AI Inc

56.590

-1.220-2.11%
Mais detalhes de Tempus AI Inc Empresa
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. The Company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Its product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Informações da empresa
Código da empresaTEM
Nome da EmpresaTempus AI Inc
Data de listagemJun 14, 2024
Fundado em2015
CEOMr. Eric P. Lefkofsky, J.D.
Número de funcionários2400
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 14
Endereço600 West Chicago Avenue
CidadeCHICAGO
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal60654
Telefone18009765448
Sitehttps://www.tempus.com/
Código da empresaTEM
Data de listagemJun 14, 2024
Fundado em2015
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
892.28K
-2.19%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
104.02K
+1.96%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
16.70K
+13.58%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
12.87K
-72.80%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
5.48K
-75.79%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
5.17K
-4.61%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
3.25K
+159.76%
Dr. Wayne A.I. Frederick, M.D.
Dr. Wayne A.I. Frederick, M.D.
Independent Director
Independent Director
--
--
Mr. Theodore John (Ted) Leonsis
Mr. Theodore John (Ted) Leonsis
Independent Director
Independent Director
--
--
Dr. Jennifer A. Doudna, Ph.D.
Dr. Jennifer A. Doudna, Ph.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
892.28K
-2.19%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
104.02K
+1.96%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
16.70K
+13.58%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
12.87K
-72.80%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
5.48K
-75.79%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
5.17K
-4.61%
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Blue Media, LLC
15.37%
BK TL21 LLC
9.05%
Baillie Gifford & Co.
7.31%
Red Sky LLC
5.65%
Gray Media, LLC
5.60%
Other
57.02%
Investidores
Investidores
Proporção
Blue Media, LLC
15.37%
BK TL21 LLC
9.05%
Baillie Gifford & Co.
7.31%
Red Sky LLC
5.65%
Gray Media, LLC
5.60%
Other
57.02%
Tipos de investidores
Investidores
Proporção
Corporation
35.67%
Investment Advisor
22.35%
Investment Advisor/Hedge Fund
6.45%
Individual Investor
4.35%
Holding Company
3.22%
Research Firm
2.92%
Hedge Fund
2.54%
Venture Capital
2.48%
Sovereign Wealth Fund
0.62%
Other
19.41%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
486
136.65M
81.30%
-3.52M
2025Q1
444
136.54M
81.24%
-3.30M
2024Q4
259
141.87M
89.45%
+26.80M
2024Q3
171
136.39M
89.94%
+26.38M
2024Q2
115
132.44M
88.72%
+132.44M
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Blue Media, LLC
25.83M
15.37%
-762.35K
-2.87%
Mar 31, 2025
BK TL21 LLC
15.22M
9.05%
--
--
Mar 18, 2025
Baillie Gifford & Co.
12.29M
7.31%
-1.46M
-10.62%
Mar 31, 2025
Red Sky LLC
9.50M
5.65%
-2.06M
-17.83%
Mar 31, 2025
Gray Media, LLC
9.41M
5.6%
-150.00K
-1.57%
Mar 31, 2025
ARK Investment Management LLC
7.50M
4.46%
+1.98M
+35.90%
Mar 31, 2025
The Vanguard Group, Inc.
6.00M
3.57%
+5.90M
+6247.46%
Mar 31, 2025
SoftBank Group Corp
5.41M
3.22%
--
--
Mar 31, 2025
Lefkofsky (Eric Paul)
4.54M
2.7%
-16.75K
-0.37%
May 20, 2025
Nikko Asset Management Co., Ltd.
4.26M
2.53%
+1.02M
+31.38%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: dom, 6 de jul
Atualizado em: dom, 6 de jul
Nome
Proporção
ARK Genomic Revolution ETF
9.57%
ARK Innovation ETF
5.2%
Renaissance IPO ETF
4.3%
Global X HealthTech ETF
3.79%
ROBO Global Artificial Intelligence ETF
2.49%
ROBO Global Healthcare Technology & Innovation ETF
2.08%
KraneShares Artificial Intelligence and Tcnlgy ETF
1.96%
AXS Green Alpha ETF
1.9%
First Trust Nasdaq AI and Robotics ETF
1.67%
Franklin Genomic Advancements ETF
1.35%
Ver Mais
ARK Genomic Revolution ETF
Proporção9.57%
ARK Innovation ETF
Proporção5.2%
Renaissance IPO ETF
Proporção4.3%
Global X HealthTech ETF
Proporção3.79%
ROBO Global Artificial Intelligence ETF
Proporção2.49%
ROBO Global Healthcare Technology & Innovation ETF
Proporção2.08%
KraneShares Artificial Intelligence and Tcnlgy ETF
Proporção1.96%
AXS Green Alpha ETF
Proporção1.9%
First Trust Nasdaq AI and Robotics ETF
Proporção1.67%
Franklin Genomic Advancements ETF
Proporção1.35%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI